You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
12 month hackathon, Scenario 2 ( Model extraction and simulation for SV2AIR3 full version)
Extend the model to incorporate multiple strains and 2 vaccine types, according to publication Fig. 1B and equations #2-12.
a. (TA 1 Model Extraction Workflow) Get the extended model by extracting it directly from the publication, and code at https://github.com/MehrshadSD/SARS-CoV-2-variants-of-concern-in-Ontario.
c. (TA3 Simulation Workflows/ Unit Tests) As in the paper, simulate the spread of Covid-19 in Ontario, over a 2 year period from January 1st, 2020 – December 31st, 2021, incorporating 2 vaccine types (Pfizer and AstraZeneca), and 3 Covid-19 variants/strains (including Wild Type, Alpha, and Delta, ignoring Omicron at the end of 2021). Set parameter values according to publication supplementary material. Use the 2019 population of Ontario, 14.57 million people. For initial conditions, assume the entire population was susceptible at the beginning of the simulation timeframe, except for 15 infected symptomatic individuals.
Reproduce Figs. 3a, b, d, and e.
Problem 2a
Problem 2b
Problem 2c
Inputs
SV2AIR3 publication + accompanying code
Extracted model from Problem 1
Either model from 2a or 2b
Parameters: as described in publication and supplementary material document
Task
Extract full SV2AIR3 model
Extend model to create full SV2AIR3 model
Run simulation for January 1st, 2020 – December 31st
Outputs
Extracted model
Extended model, compare against 2a
Reproduce Figs. 3a, b, d, and e.
The text was updated successfully, but these errors were encountered:
djinnome
changed the title
12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
September epi scenario 3.1: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
Sep 24, 2024
djinnome
changed the title
September epi scenario 3.1: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
September epi scenario 3 part 2: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
Sep 24, 2024
djinnome
changed the title
September epi scenario 3 part 2: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
September problem 3 part 2: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
Sep 24, 2024
djinnome
changed the title
September problem 3 part 2: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
September problem 3 part 2: 12 month hackathon Scenario 2 Q2a-c (Model extraction and simulation for SV2AIR3 full version)
Sep 26, 2024
djinnome
changed the title
September problem 3 part 2: 12 month hackathon Scenario 2 Q2a-c (Model extraction and simulation for SV2AIR3 full version)
September problem 3 part 2: 12 month hackathon Scenario 2 Q2a,c (Model extraction and simulation for SV2AIR3 full version)
Sep 26, 2024
12 month hackathon, Scenario 2 ( Model extraction and simulation for SV2AIR3 full version)
Extend the model to incorporate multiple strains and 2 vaccine types, according to publication Fig. 1B and equations #2-12.
a. (TA 1 Model Extraction Workflow) Get the extended model by extracting it directly from the publication, and code at https://github.com/MehrshadSD/SARS-CoV-2-variants-of-concern-in-Ontario.
c. (TA3 Simulation Workflows/ Unit Tests) As in the paper, simulate the spread of Covid-19 in Ontario, over a 2 year period from January 1st, 2020 – December 31st, 2021, incorporating 2 vaccine types (Pfizer and AstraZeneca), and 3 Covid-19 variants/strains (including Wild Type, Alpha, and Delta, ignoring Omicron at the end of 2021). Set parameter values according to publication supplementary material. Use the 2019 population of Ontario, 14.57 million people. For initial conditions, assume the entire population was susceptible at the beginning of the simulation timeframe, except for 15 infected symptomatic individuals.
Reproduce Figs. 3a, b, d, and e.
The text was updated successfully, but these errors were encountered: